93 3165 93 3165 Pill - pink capsule/oblong, 16mm
Pill with imprint 93 3165 93 3165 is Pink, Capsule/Oblong and has been identified as Minocycline Hydrochloride 50 mg. It is supplied by Teva Pharmaceuticals USA.
Minocycline is used in the treatment of Acne; Bacterial Infection; Bartonellosis; Actinomycosis; Bullous Pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 3165 93 3165
Minocycline Hydrochloride
- Imprint
- 93 3165 93 3165
- Strength
- 50 mg
- Color
- Pink
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-3165 (Discontinued)
- Inactive Ingredients
-
corn starch,
magnesium stearate,
titanium dioxide,
D&C Red No. 33,
FD&C Red No. 3,
FD&C Yellow No. 6,
ferrosoferric oxide,
propylene glycol,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
shellac,
ammonia
Note: Inactive ingredients may vary.
Related images for "93 3165 93 3165"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (560)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline (Oral) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Solodyn, Dynacin, Minolira, ... +2 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Solodyn, Minolira, Minocin for Injection, Ximino
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
